LV9 Stock Overview
Engages in the production, cultivation, and sale of cannabis products for medical purpose in Canada.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Lotus Ventures Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.0005 |
52 Week High | CA$0.028 |
52 Week Low | CA$0.0005 |
Beta | -0.32 |
11 Month Change | 0% |
3 Month Change | 0% |
1 Year Change | -97.67% |
33 Year Change | -99.44% |
5 Year Change | -99.55% |
Change since IPO | -99.77% |
Recent News & Updates
Recent updates
Shareholder Returns
LV9 | DE Pharmaceuticals | DE Market | |
---|---|---|---|
7D | 0% | -7.0% | -0.1% |
1Y | -97.7% | -19.7% | 2.4% |
Return vs Industry: LV9 underperformed the German Pharmaceuticals industry which returned -19.7% over the past year.
Return vs Market: LV9 underperformed the German Market which returned 2.4% over the past year.
Price Volatility
LV9 volatility | |
---|---|
LV9 Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 5.6% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.3% |
10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: LV9 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine LV9's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Dale McClanaghan | www.lotuscannabis.ca |
Lotus Ventures Inc. engages in the production, cultivation, and sale of cannabis products for medical purpose in Canada. It owns Lotus Cannabis Co., a premium-craft consumer brand and sells its Keylime Kush flower and prerolls in British Columbia. The company is based in Vancouver, Canada.
Lotus Ventures Inc. Fundamentals Summary
LV9 fundamental statistics | |
---|---|
Market cap | €780.27k |
Earnings (TTM) | -€1.27m |
Revenue (TTM) | €1.35m |
0.6x
P/S Ratio-0.6x
P/E RatioIs LV9 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
LV9 income statement (TTM) | |
---|---|
Revenue | CA$2.00m |
Cost of Revenue | CA$2.14m |
Gross Profit | -CA$137.15k |
Other Expenses | CA$1.74m |
Earnings | -CA$1.87m |
Last Reported Earnings
Aug 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.016 |
Gross Margin | -6.86% |
Net Profit Margin | -93.71% |
Debt/Equity Ratio | 26.7% |
How did LV9 perform over the long term?
See historical performance and comparison